Hologic Inc. (HOLX) President & COO Robert Cascella sells 140,000 Shares

Author's Avatar
Aug 18, 2009
President & COO of Hologic Inc. (HOLX, Financial) Robert Cascella sells 140,000 shares of HOLX on 08/14/2009 at an average price of $14.83 a share.

Hologic Inc. is a leading supplier of high quality innovative and clinically valuable diagnostic systems and tests. The company develops manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key element of women\'s health care. The systems are used by more leading medical schools universities and osteoporosis opinion leaders than any other bone densitometer. Hologic Inc. has a market cap of $3.81 billion; its shares were traded at around $14.84 with a P/E ratio of 12.5 and P/S ratio of 2.3. Hologic Inc. had an annual average earning growth of 127.1% over the past 5 years.

HOLX is in the portfolios of Irving Kahn of Kahn Brothers & Company Inc., George Soros of Soros Fund Management LLC, Ronald Muhlenkamp of Muhlenkamp Fund, Richard Aster Jr of Meridian Fund, Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC.

Recent Trades of Hologic Inc. by Directors and Officers:
  • Buy: SVP, Diagnostics Products Howard Jr Doran bought 3,500 shares of HOLX stock on 05/19/2009 at the average price of $11.97; the price of the stock has increased by 23.98% since.

  • Sell: SVP, Human Resources David J Brady sold 25,000 shares of HOLX stock on 08/06/2009 at the average price of $14.3; the price of the stock has increased by 3.78% since.